(Q36423131)

14 August 2017

1 reference

title

5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives (English)

1 reference

14 August 2017

1 reference

4

Robert Gurny

1 reference

14 August 2017

Nicolas Fotinos

1

1 reference

14 August 2017

Marino A Campo

series ordinal

2

1 reference

14 August 2017

Florence Popowycz

series ordinal

3

1 reference

14 August 2017

Norbert Lange

series ordinal

5

1 reference

14 August 2017

publication date

1 July 2006

1 reference

Photochemistry and Photobiology

14 August 2017

published in

1 reference

14 August 2017

volume

82

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

994-1015

1 reference

The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Chemical Aspects of Selective Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A compilation of singlet oxygen yields from biologically relevant molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

The fluid mosaic model of the structure of cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Passive skin penetration enhancement and its quantification in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Porphyrin accumulation induced by 5-aminolaevulinic acid esters in tumour cells growing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor gamma-vinyl-GABA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Screening for skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Actinic keratosis: epidemiology and progression to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Current and novel treatment options for actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Diagnosis of urothelial carcinoma of the bladder using fluorescence endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Fluorescence detection of bladder cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Treatment for cervical intraepithelial neoplasia and risk of preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Time-dependent hexaminolaevulinate induced protoporphyrin IX distribution after topical application in patients with cervical intraepithelial neoplasia: A fluorescence microscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Detection of dysplastic lesions by fluorescence in a model of chronic colitis in rats after local application of 5-aminolevulinic acid and its esterified derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

A hydroxypyridinone (CP94) enhances protoporphyrin IX formation in 5-aminolaevulinic acid treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Self-adhesive thin films for topical delivery of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Optimization of aminolevulinic acid delivery by iontophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1562%2F2006-02-03-IR-794

10.1562/2006-02-03-IR-794

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference